LPTX - Leap Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Leap Therapeutics's activity chart (see below) currently has 7 price targets and 12 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.67% with an average time for these price targets to be met of 304.2 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 27-Mar-2025. First documented stock forecast 07-Mar-2017.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 27-Mar-2025

Buy Since 03-Jun-2021

$6.95 (339.02%)

Buy Since 17-May-2021

Buy Since 05-Oct-2021

Buy Since 05-Apr-2022

Show more analysts

What is LPTX (Leap Therapeutics) average time for price targets to be met?

On average it took 304.2 days on average for the stock forecasts to be realized with a an average price target met ratio 36.67

Which analyst has the current highest performing score on LPTX (Leap Therapeutics) with a proven track record?

TYLER VAN BUREN

Which analyst has the most public recommendations on LPTX (Leap Therapeutics)?

Tyler Van Buren works at TD COWEN and has 28 price targets and 20 ratings on LPTX

Which analyst is the currently most bullish on LPTX (Leap Therapeutics)?

Wangzhi Li with highest potential upside - $77.95

Which analyst is the currently most reserved on LPTX (Leap Therapeutics)?

Joseph Catanzaro with lowest potential downside - -$0